反应详情

温度

100 °C

A mixture of 6-chloro-N-(6-(pyrrolidin-1-yl)pyridin-2-yl)imidazo[1,2-b]pyridazin-8-amine (52 mg, 0.17 mmol), phenylboronic acid (31 mg, 0.25 mmol), Pd2(dba)3 (10 mg, 0.017 mmol), X-phos (32 mg, 0.067 mmol) and K2CO3 (69 mg, 0.5 mmol) in dioxane (5 mL) and water (0.5 mL) was heated to 100° C. with stirring for 4 h under N2. The solvent was removed in vacuo and the resulting mixture was purified by chromatography (silica gel, 200-300 mesh, CH2Cl2:MeOH=180:1) to give crude product as a yellow solid. The solid was further purified by prep-HPLC (Gemini 5u C18 150×21.2 mm; inject volume: 3 mL/inj, flow rate: 20 mL/min; wavelength: 214 nm and 254 nm; gradient conditions: 20% acetonitrile/80% water (0.1% TFA, v/v) initially, proceeding to 40% acetonitrile/60% water (0.1% TFA, v/v) in a linear fashion over 9 min) to give a light yellow solid. This was dissolved in methanol and three drops of concentrated HCl added. The mixture was stirred for 5 minutes, then concentrated in vacuo to give the final product 6-phenyl-N-(6-(pyrrolidin-1-yl)pyridin-2-yl)imidazo[1,2-b]pyridazin-8-amine hydrochloride (46 mg, 78%) as an HCl salt. 1H NMR (300 MHz, CD3OD): δ 8.81 (s, 1H), 8.31 (s, 1H), 8.04-7.96 (m, 3H), 7.56-7.50 (m, 4 h), 6.38 (d, 1H, J=7.8 Hz), 6.20 (d, 1H, J=8.4 Hz), 3.54-3.49 (m, 4 h), 2.08-2.03 (m, 4 h). LC-MS: [M+H]+, 357.1, tR=1.912 min, HPLC: 95.34% at 214 nm, 99.67% at 254 nm, tR=7.083 min.

1. customThe solvent was removed in vacuo
2. customthe resulting mixture was purified by chromatography (silica gel, 200-300 mesh, CH2Cl2:MeOH=180:1)
3. customto give crude product as a yellow solid
4. customThe solid was further purified by prep-HPLC (Gemini 5u C18 150×21.2 mm
5. waitgradient conditions: 20% acetonitrile/80% water (0.1% TFA, v/v) initially, proceeding to 40% acetonitrile/60% water (0.1% TFA, v/v) in a linear fashion over 9 min
6. custom) to give a light yellow solid
7. stirringThe mixture was stirred for 5 minutes
8. concentrationconcentrated in vacuo